⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FULC News
Fulcrum Therapeutics, Inc. Common Stock
Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeutics, Inc. (FULC)
prnewswire.com
FULC
Fulcrum Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
globenewswire.com
FULC
FULC INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Fulcrum Therapeutics, Inc.
globenewswire.com
FULC
Form 8-K
sec.gov
FULC
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
globenewswire.com
FULC
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FULC
Form 8-K
sec.gov
FULC
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
globenewswire.com
FULC
Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors
globenewswire.com
FULC
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
globenewswire.com
FULC